Peptide formulary · Blend
GLOW
GLOW is a compounded blend that pairs the repair-and-recovery peptides BPC-157 and TB-500 with KPV, a small peptide studied for calming inflammatory signaling. Dr. Luria may prescribe it within protocols focused on recovery, skin comfort, and inflammatory balance.
A compounded peptide blend combining BPC-157, KPV, and TB-500, used in protocols for recovery, skin comfort, and inflammatory balance.
Class
Compounded peptide blend (BPC-157 + KPV + TB-500)
Administration
Subcutaneous injection; typically daily
Typical goals
Recovery, skin comfort, inflammatory balance
What it is
GLOW, in plain language.
GLOW is a single compounded preparation that combines three peptides in one protocol. It is prescribed and dispensed as a blend, not assembled by the patient.
BPC-157 and TB-500 are the repair-and-recovery peptides described elsewhere in this formulary. KPV is a small α-MSH-derived peptide studied for calming inflammatory signaling, with interest in gut and skin comfort, which is where its contribution to this blend comes in.
Dr. Luria positions GLOW as one option within a broader plan, and reviews the developing evidence base for each component honestly during the consultation.
Mechanism
How glow works in the body.
BPC-157 is studied for angiogenesis and growth-factor signaling involved in tissue repair, and TB-500 for cell migration and connective-tissue flexibility.
KPV is studied for its influence on inflammatory pathways, both systemically and locally in the gut and skin, the basis for its interest in comfort-oriented goals.
Much of the evidence for these peptides remains preclinical. Dr. Luria monitors response over time and adjusts the protocol accordingly.
Who it's typically for
The patient profile.
GLOW is most often considered for adults pursuing recovery alongside skin and inflammatory comfort, typically as one element of a broader, supervised plan.
Dr. Luria evaluates whether the blend fits your goals and clinical picture and is candid when a different approach makes more sense.
What patients commonly report
Reported experiences.
Skin comfort
Patients pursuing skin-related goals have reported improvements in comfort over time; individual and variable.
Recovery
Some describe feeling they recover more comfortably from training.
Inflammatory comfort
Some report a general sense of improved comfort over a course.
Resilience
Many report a general sense of well-being over a multi-week protocol.
Individual response varies. Much of the evidence is preclinical, not every patient experiences every benefit, and timelines differ.
Common questions
GLOW, answered.
What's in GLOW?
Is GLOW FDA-approved?
How is it taken?
Considerations
When glow may not be appropriate.
GLOW is generally not appropriate during pregnancy or breastfeeding, with active malignancy, or alongside certain medical conditions, and long-term human safety data for its components are limited. Full evaluation happens in consultation before any protocol is set.
Related reading
Go deeper.
Begin
Is glow right for you?
Book a consultation with Dr. Luria to discuss your goals and whether glow or a different protocol fits your clinical picture.
This article is educational and does not constitute medical advice. Decisions about peptide therapy should be made in consultation with a licensed physician who has reviewed your individual health history. GLOW is a compounded prescription prepared by Blue Atlas Pharmacy, a licensed 503A compounding pharmacy, under the prescription of Dr. Jamie Luria. Compounded medications are not FDA-approved for safety, efficacy, or quality.